The company stopped selling the device following a warning by the U.S. Food and Drug Administration saying morcellators present a serious risk of spreading cancerous tissue.
In March, Massachusetts General Hospital and Brigham and Women’s Hospital in Boston changed their protocols on morcellation procedures after two cases resulted in the spreading of cancerous tissue into the abdomen.
More Articles on Hospital Supply Chain:
FDA Proposes Reclassifying Surgical Mesh as ‘High-Risk Device’
Drug Supply Chain & Security Act Implementation Timeline
6 Strategies to Conserve IV Solution
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
